Sign In
Buy ISEE
$39.95
+0 (+0%)
At Close: Oct 09, 2023
Iveric Bio to Report Second Quarter 2022 Financial Results and Host Conference Call on Tuesday, July 26, 2022
04:18pm, Thursday, 21'st Jul 2022
PARSIPPANY, N.J.--(BUSINESS WIRE)--Iveric Bio announced that it will report its second quarter 2022 financial and operating results on Tuesday, July 26, 2022.
Trial Results Set to Make or Break Small-Cap Pharma Stocks
04:15pm, Wednesday, 06'th Jul 2022
One analyst is putting the odds at three to one that tests of a Karuna Therapeutics Inc. ( KRTX , Financial) schizophrenia drug will meet study objectives, paving the way to Food and Drug Administrati
IVERIC bio: A First Take
02:16pm, Thursday, 23'rd Jun 2022
Today, we take our first look at ocular focused biotech IVERIC bio, Inc. The stock has seen some insider buying here in June and its primary asset Zumira seems on the path to commercialization.
Biopharmaceutical Stocks: The Bottoming Process Is Playing Out
02:30pm, Wednesday, 08'th Jun 2022
Three weeks ago, I suggested that the severe correction in biopharmaceutical stocks had ended. I expect the bottoming process to be choppy with a bias to the upside. The antecedent cause of the declin
Benzinga's Top Ratings Upgrades, Downgrades For June 8, 2022
02:03pm, Wednesday, 08'th Jun 2022 Benzinga
Upgrades
For Crescent Point Energy Corp (NYSE:CPG), Scotiabank upgraded the previous rating of Sector Perform to Sector Outperform. In the first quarter, Crescent Point Energy showed an EPS of $0.32,
Iveric Bio to Present at the UBS Global Healthcare Conference 2022
08:00am, Tuesday, 17'th May 2022
PARSIPPANY, N.J.--(BUSINESS WIRE)--Iveric Bio announced that Pravin U. Dugel, M.D., will participate in a fireside chat at the UBS Global Healthcare Conference 2022 on May 23, 2022.
Benzinga's Top Ratings Upgrades, Downgrades For May 12, 2022
02:04pm, Thursday, 12'th May 2022 Benzinga
Upgrades
For Warner Bros.Discovery Inc (NASDAQ:WBD), Cowen & Co. upgraded the previous rating of Market Perform to Outperform. The current stock performance of Warner Bros.Discovery shows a 52-week-h
IVERIC bio, Inc. (ISEE) Q1 2022 Earnings Call Transcript
05:00pm, Wednesday, 04'th May 2022 The Motley Fool
ISEE earnings call for the period ending March 31, 2022.
IVERIC bio, Inc. (ISEE) CEO Glenn Sblendorio on Q1 2022 Results - Earnings Call Transcript
02:04pm, Wednesday, 04'th May 2022
IVERIC bio, Inc. (NASDAQ:ISEE ) Q1 2022 Earnings Conference Call May 4, 2022 8:00 AM ET Company Participants Kathy Galante - SVP of IR Glenn Sblendorio - CEO Pravin Dugel - President Keith Westby - CO
10 Small Cap Stocks With Strong Buy Recommendations
05:17am, Monday, 28'th Mar 2022 Investing.com
Benzinga's Top Ratings Upgrades, Downgrades For March 22, 2022
02:03pm, Tuesday, 22'nd Mar 2022 Benzinga
Upgrades
For Procter & Gamble Co (NYSE:PG), Truist Securities upgraded the previous rating of Hold to Buy. For the second quarter, Procter & Gamble had an EPS of $1.66, compared to year-ago quarter EP
Wednesdays With Wedbush: 3 Smid-Cap Biotech Stock Picks
05:03pm, Wednesday, 09'th Mar 2022 Benzinga
Since the coronavirus pandemic began in early 2020, the FDA's plate has been full with reviews of COVID-19 vaccines and treatments. That has put the approval of many other drugs and therapies on the
Wednesdays With Wedbush: 3 Smid-Cap Biotech Stock Picks
12:03pm, Wednesday, 09'th Mar 2022
Since the coronavirus pandemic began in early 2020, the FDA's plate has been full with reviews of COVID-19 vaccines and treatments. That has put the approval of many other drugs and therapies on the
Learning Lessons From 3 Stocks Flourishing In A Desperate Biotech Bear Market
02:25pm, Tuesday, 08'th Mar 2022
Biotech has been the worst performing sector of the stock market across the past 12 months.
Benzinga's Top Ratings Upgrades, Downgrades For March 3, 2022
03:03pm, Thursday, 03'rd Mar 2022 Benzinga
Upgrades
For Douglas Emmett Inc (NYSE:DEI), Evercore ISI Group upgraded the previous rating of In-Line to Outperform. For the fourth quarter, Douglas Emmett had an EPS of $0.48, compared to year-ago q
